EGFR gene-mutation status correlated with therapeutic decision making in lung adenocarcinoma

The purpose of this study was to investigate the correlation between EGFR-mutation status and treatment efficacy for advanced lung adenocarcinoma patients. A total of 47 patients receiving erlotinib as first-line therapy were divided into two groups: the EGFR gene mutation group included 19 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Yaoyao, Yao, Yibing, Ma, Qing, Zhong, Diansheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621216/
https://www.ncbi.nlm.nih.gov/pubmed/26527887
http://dx.doi.org/10.2147/OTT.S87146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621216/
https://www.ncbi.nlm.nih.gov/pubmed/26527887
http://dx.doi.org/10.2147/OTT.S87146

Ejemplares similares